Harmon County Board of County Commissioners v. Cephalon Inc et al
Harmon County Board of County Commissioners |
Cephalon Inc, Janssen Pharmaceutica Inc, Mallinckrodt LLC, Mallinckrodt plc, Watson Pharma Inc, Ortho-McNeil-Janssen Pharmaceuticals Inc, Allergan plc, Endo Health Solutions Inc, Teva Pharmaceuticals USA Inc, Actavis plc, McKesson Corp, Teva Pharmaceutical Industries Ltd, Mylan Pharmaceuticals Inc, Watson Laboratories Inc, Johnson & Johnson, Watson Pharmaceuticals Inc, GCP Pharma LLC, Allergan Finance, LLC f/k/a Actavis, Inc. f/k/a Watson Pharmaceuticals, Inc., SPECGX LLC, Par Pharmaceutical Inc, Cardinal Health Inc, Janssen Pharmaceuticals Inc, Actavis LLC, Morris & Dickson Co LLC, Actavis Pharma Inc, Amerisourcebergen Drug Corp and Endo Pharmaceuticals Inc |
OKW/5:20-CV-00850 |
August 24, 2020 |
Judicial Panel on Multidistrict Litigation |
Timothy D DeGiusti |
Other |
Docket Report
This docket was last retrieved on October 22, 2020. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 29 HEARING ORDER re: pldg. (6 in ALS/1:20-cv-00438, #8609 in MDL No. 2804), (8 in ALS/1:20-cv-00440, #8642 in MDL No. 2804), (8 in ALS/1:20-cv-00443, #8610 in MDL No. 2804), (31 in CAE/2:20-cv-01824, #8649 in MDL No. 2804), (30 in KYE/7:20-cv-00102, #8343 in MDL No. 2804), ( #8522 in MDL No. 2804, 7 in MSN/3:20-cv-00248), ( #8679 in MDL No. 2804, 18 in MOE/4:20-cv-01252), ( #8556 in MDL No. 2804, 20 in OKW/5:20-cv-00850), ( #8612 in MDL No. 2804, 21 in MOE/4:20-cv-01191, 21 in MOE/4:20-cv-01195), ( #8518 in MDL No. 2804, 26 in MOE/4:20-cv-01121), ( #8547 in MDL No. 2804, 21 in MOE/4:20-cv-01125, 20 in MOE/4:20-cv-01136, 19 in MOE/4:20-cv-01150), ( #8429 in MDL No. 2804, 6 in VAE/3:20-cv-00606), ( #8383 in MDL No. 2804, 12 in PAE/2:20-cv-03695) in the following opposition(s) of Plaintiffs and defendant North Mississippi Center in 16 Actions - ALS-3, CAE-1, KYE-1, MSN-1, MOE-7, OKW-1, PAE-1, VAE-1 - SECTION B (DESIGNATED FOR CONSIDERATION WITHOUT ORAL ARGUMENT) PANEL HEARING set for 12/3/2020 in Washington, DC.Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 10/22/2020. Associated Cases: MDL No. 2804, ALS/1:20-cv-00438, ALS/1:20-cv-00440, ALS/1:20-cv-00443, CAE/2:20-cv-01824, KYE/7:20-cv-00102, MOE/4:20-cv-01121, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, MOE/4:20-cv-01191, MOE/4:20-cv-01195, MOE/4:20-cv-01252, MSN/3:20-cv-00248, OKW/5:20-cv-00850, PAE/2:20-cv-03695, VAE/3:20-cv-00606 (RH) |
Filing 28 Joint RESPONSE IN OPPOSITION TO MOTION TO VACATE CTO (re: pldg.( 8547 in MDL No. 2804)( 8556 in MDL No. 2804) (19 in MOE/4:20-cv-01150), (20 in OKW/5:20-cv-00850) ) (CTO-171) Filed by Defendants Amerisourcebergen Corporation, #et al.Amerisourcebergen Drug Corporation, Cardinal Health, Inc., McKesson Corporation. #[Suppress List] (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Mainigi, Enu) Modified on 10/16/2020 (SM). ADDED MDL LINK. DELETED DUPLICATE PARTY NAMES |
Filing 27 Joint RESPONSE IN OPPOSITION TO MOTION TO VACATE CTO (re: pldg.( 8547 in MDL No. 2804)( 8556 in MDL No. 2804) ( 8461 in MDL No. 2804, 3 in OKW/5:20-cv-00850), ( 8424 in MDL No. 2804, 4 in MOE/4:20-cv-01125, 4 in MOE/4:20-cv-01136, 3 in MOE/4:20-cv-01150) ) (CTO-171) Filed by Defendants Actavis LLC, #et al.Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. #[Suppress List] (Attachments: #1 Proof of Service, #2 Service List) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Reed, Steven) Modified on 10/16/2020 (SM). ADDED MDL LINK. DELETED DUPLICATE PARTY NAMES |
Filing 26 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #8461 in MDL No. 2804, 3 in OKW/5:20-cv-00850), ( #8424 in MDL No. 2804, 4 in MOE/4:20-cv-01125, 4 in MOE/4:20-cv-01136, 3 in MOE/4:20-cv-01150) -- Identifying Corporate Parent No Parent Corp. for Mallinckodt, PLC. Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (O'Connor, Brien) |
Filing 25 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #8461 in MDL No. 2804, 3 in OKW/5:20-cv-00850), ( #8424 in MDL No. 2804, 4 in MOE/4:20-cv-01125, 4 in MOE/4:20-cv-01136, 3 in MOE/4:20-cv-01150) -- Identifying Corporate Parent Mallinckrodt, PLC for SPECGX LLC.. Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (O'Connor, Brien) |
Filing 24 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #8461 in MDL No. 2804, 3 in OKW/5:20-cv-00850), ( #8424 in MDL No. 2804, 4 in MOE/4:20-cv-01125, 4 in MOE/4:20-cv-01136, 3 in MOE/4:20-cv-01150) -- Identifying Corporate Parent Mallinckrodt, PLC for Mallinckrodt LLC. Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (O'Connor, Brien) |
Filing 23 NOTICE OF APPEARANCE FOR CTO-171 re: pldg. ( #8419 in MDL No. 2804, 2 in MOE/4:20-cv-01125, 2 in MOE/4:20-cv-01136, 1 in MOE/4:20-cv-01150, 1 in OKW/5:20-cv-00850) Filed by Brien T. O'Connor on behalf of Defendants Mallinckodt, PLC, Mallinckrodt LLC, Specgx LLC Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (O'Connor, Brien) |
Filing 22 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 8461 in MDL No. 2804, 3 in OKW/5:20-cv-00850), ( 8556 in MDL No. 2804, 20 in OKW/5:20-cv-00850), ( 8547 in MDL No. 2804, 21 in MOE/4:20-cv-01125, 20 in MOE/4:20-cv-01136, 19 in MOE/4:20-cv-01150), ( 8424 in MDL No. 2804, 4 in MOE/4:20-cv-01125, 4 in MOE/4:20-cv-01136, 3 in MOE/4:20-cv-01150) -- Identifying Corporate Parent Endo International plc for Endo Health Solutions Inc, Endo Pharmaceuticals Inc, PAR Pharmaceutical, Inc., Par Pharmaceutical Companies, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Stern, Jonathan) Modified on 9/28/2020 (SM). DELETED DUPLICATE PARTY NAMES |
Filing 21 NOTICE OF APPEARANCE FOR CTO-171 re: pldg. ( 8419 in MDL No. 2804, 2 in MOE/4:20-cv-01125, 2 in MOE/4:20-cv-01136, 1 in MOE/4:20-cv-01150, 1 in OKW/5:20-cv-00850) Filed by Jonathan L. Stern on behalf of Defendants Endo Health Solutions Inc., #et al.Endo Pharmaceuticals, Inc., PAR Pharmaceutical, Inc., Par Pharmaceutical Companies, Inc. #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Stern, Jonathan) Modified on 9/29/2020 (SM). DELETED DUPLICATE PARTY NAMES |
Filing 20 MOTION TO VACATE CONDITIONAL TRANSFER ORDER WITH BRIEF IN SUPPORT (CTO-171) re: pldg. ( 8464 in MDL No. 2804, 4 in OKW/5:20-cv-00850), ( #8461 in MDL No. 2804, 3 in OKW/5:20-cv-00850) Filed by Plaintiff Harmon County Board of County Commissioners (Attachments: #1 Brief, #2 Schedule of Actions, #3 Proof of Service) Associated Cases: MDL No. 2804, OKW/5:20-cv-00850 (Sill, Matthew) |
Filing 19 NOTICE OF APPEARANCE FOR CTO-171 re: pldg. ( #8419 in MDL No. 2804, 1 in OKW/5:20-cv-00850) Filed by Matthew J. Sill on behalf of Plaintiff Harmon County Board of County Commissioners (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2804, OKW/5:20-cv-00850 (Sill, Matthew) |
Filing 18 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 8424 in MDL No. 2804) ( 8461 in MDL No. 2804)(4 in MOE/4:20-cv-01125, 4 in MOE/4:20-cv-01136, 3 in MOE/4:20-cv-01150), (3 in OKW/5:20-cv-00850) -- Identifying Corporate Parent Cardinal Health, Inc. for Cardinal Health 100, Inc. Cardinal Health 108, LLC, Cardinal Health 110 LLC, Cardinal Health 5, LLC, Cardinal Health Pharmacy Services, LLC. Corporate Parent Cardinal Health Pharmacy Services, LLC for Cardinal Health 132, LLC. Corporate Parent Allegiance Corp. for Cardinal Health 200, LLC, Cardinal Health 201, Inc. Corporate Parent Cardinal Health 110, LLC for Cardinal Health 113, LLC. Corporate Parent No Parent Corp. for Cardinal Health Inc. Corporate Parent Cardinal Health 121, LLC for Cardinal Health 122, LLC. Corporate Parent Cardinal Health 100, Inc. for Cardinal Health 414, LLC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Mainigi, Enu) Modified on 9/28/2020 (SM). ADDED MDL LINK. DELETED DUPLICATE PARTY NAMES |
Filing 17 NOTICE OF APPEARANCE FOR CTO-171 re: pldg. ( 8419 in MDL No. 2804) (2 in MOE/4:20-cv-01125, 2 in MOE/4:20-cv-01136, 1 in MOE/4:20-cv-01150, 1 in OKW/5:20-cv-00850) Filed by Enu Mainigi on behalf of Defendants Cardinal Health 100, Inc., Cardinal Health 108, LLC, Cardinal Health 110, LLC, Cardinal Health 113, LLC, Cardinal Health 122, LLC, Cardinal Health 132, LLC, Cardinal Health 200, LLC, Cardinal Health 201, Inc., Cardinal Health 414, LLC, Cardinal Health 5, LLC, Cardinal Health Pharmacy Services, LLC, Cardinal Health, Inc., Cardinal Health 100, Inc., Cardinal Health 108, LLC, Cardinal Health 110 LLC, Cardinal Health 113, LLC, Cardinal Health 122, LLC, Cardinal Health 132, LLC, Cardinal Health 200, LLC, Cardinal Health 201, Inc., Cardinal Health 414, LLC, Cardinal Health 5, LLC, Cardinal Health Pharmacy Services, LLC, Cardinal Health, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Mainigi, Enu) Modified on 9/28/2020 (SM). ADDED MDL LINK. DELETED DUPLICATE PARTY NAMES |
Filing 16 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 8461 in MDL No. 2804, 3 in OKW/5:20-cv-00850), ( 8424 in MDL No. 2804, 4 in MOE/4:20-cv-01125, 3 in MOE/4:20-cv-01150) -- Identifying Corporate Parent No Parent Corp. for McKesson Corp. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Jessee, Russell) Modified on 9/28/2020 (SM). DELETED DUPLICATE PARTY NAME |
Filing 15 NOTICE OF APPEARANCE FOR CTO-171 re: pldg. ( 8419 in MDL No. 2804, 2 in MOE/4:20-cv-01125, 1 in MOE/4:20-cv-01150, 1 in OKW/5:20-cv-00850) Filed by Russell David Jessee on behalf of Defendants McKesson Corporation (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Jessee, Russell) Modified on 9/28/2020 (SM).DELETED DUPLICATE PARTY NAME |
Filing 14 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #8461 in MDL No. 2804, 3 in OKW/5:20-cv-00850) -- Identifying Corporate Parent AbbVie Inc. for Allergan plc. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2804, OKW/5:20-cv-00850 (Welch, Donna) |
Filing 13 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #8461 in MDL No. 2804, 3 in OKW/5:20-cv-00850) -- Identifying Corporate Parent AbbVie Inc. for Allergan Finance, LLC f/k/a Actavis, Inc. f/k/a Watson Pharmaceuticals, Inc.. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2804, OKW/5:20-cv-00850 (Welch, Donna) |
Filing 12 NOTICE OF APPEARANCE FOR CTO-171 re: pldg. ( 8419 in MDL No. 2804, 1 in OKW/5:20-cv-00850) Filed by Donna Marie Welch on behalf of Defendants Allergan plc, #et al.Allergan Finance, LLC f/k/a Actavis, Inc. f/k/a Watson Pharmaceuticals, Inc. #[Suppress List] (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2804, OKW/5:20-cv-00850 (Welch, Donna) Modified on 9/25/2020 (SM). DELETED DUPLICATE PARTY NAME |
Filing 11 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 8461 in MDL No. 2804, 3 in OKW/5:20-cv-00850), ( 8424 in MDL No. 2804, 4 in MOE/4:20-cv-01125, 4 in MOE/4:20-cv-01136, 3 in MOE/4:20-cv-01150) -- Identifying Corporate Parent No Parent Corp. for Johnson & Johnson. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Lifland, Charles) Modified on 9/25/2020 (SM). DELETED DUPLICATE PARTY NAME |
Filing 10 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 8461 in MDL No. 2804, 3 in OKW/5:20-cv-00850), ( 8424 in MDL No. 2804, 4 in MOE/4:20-cv-01125, 4 in MOE/4:20-cv-01136, 3 in MOE/4:20-cv-01150) -- Identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceutica Inc, Janssen Pharmaceuticals, Inc., Ortho-McNeil Jannsen Pharmaceuticals, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Lifland, Charles) Modified on 9/25/2020 (SM). DELETED DUPLICATE PARTY NAMES |
Filing 9 NOTICE OF APPEARANCE FOR CTO-171 re: pldg. ( 8419 in MDL No. 2804, 2 in MOE/4:20-cv-01125, 2 in MOE/4:20-cv-01136, 1 in MOE/4:20-cv-01150, 1 in OKW/5:20-cv-00850) Filed by Charles Coleman Lifland on behalf of Defendants Janssen Pharmaceutica, Inc., #et al.Johnson & Johnson, Ortho-McNeil Jannsen Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc. #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Lifland, Charles) Modified on 9/25/2020 (SM).DELETED DUPLICATE PARTY NAMES |
Filing 8 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 8424 in MDL No. 2804, ( 8461 in MDL No. 2804), 4 in MOE/4:20-cv-01125, 4 in MOE/4:20-cv-01136, 3 in MOE/4:20-cv-01150) -- Identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc. (Attachments: #1 Schedule of Actions, #2 Supplement, #3 Proof of Service, #4 Service List) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Reed, Steven) Modified on 9/25/2020 (SM). ADDED MDL LINK. DELETED DUPLICATE PARTY NAMES |
Filing 7 NOTICE OF APPEARANCE FOR CTO-171 re: pldg. ( 8419 in MDL No. 2804, 2 in MOE/4:20-cv-01125, 2 in MOE/4:20-cv-01136, 1 in MOE/4:20-cv-01150, 1 in OKW/5:20-cv-00850) Filed by Steven A. Reed on behalf of Defendants Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service, #3 Service List) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Reed, Steven) Modified on 9/25/2020 (SM). DELETED DUPLICATE PARTY NAMES |
Filing 6 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 8424 in MDL No. 2804) ( 8461 in MDL No. 2804) (4 in MOE/4:20-cv-01125, 4 in MOE/4:20-cv-01136, 3 in MOE/4:20-cv-01150), (3 in OKW/5:20-cv-00850) -- Identifying Corporate Parent Amerisourcebergen Services Corporation, Corporate Parent AmerisourceBergen Corporation for Amerisourcebergen Drug Corp. Corporate Parent Walgreens Boots Alliance Holdings LLC for AmeriSource Bergen Corporation. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Nicholas, Robert) Modified on 9/25/2020 (SM). ADDED MDL LINKS. DELETED DUPLICATE PARTY NAMES. |
Filing 5 NOTICE OF APPEARANCE FOR CTO-171 re: pldg.( 8419 in MDL No. 2804) (2 in MOE/4:20-cv-01125, 2 in MOE/4:20-cv-01136, 1 in MOE/4:20-cv-01150, 1 in OKW/5:20-cv-00850) Filed by Robert Arthur Nicholas on behalf of Defendants Amerisourcebergen Corporation, Amerisourcebergen Drug Corporation. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (Nicholas, Robert) Modified on 9/25/2020 (SM). ADDED MDL LINK. DELETED DUPLICATE PARTY NAMES |
Filing 4 ***TEXT ONLY NOTICE***NOTICE OF MULTIPLE FILED OPPOSITIONS TO CTO-171 AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. ( #8461 in MDL No. 2804, 3 in OKW/5:20-cv-00850), ( #8424 in MDL No. 2804, 4 in MOE/4:20-cv-01125, 4 in MOE/4:20-cv-01136, 3 in MOE/4:20-cv-01150) BRIEFING SCHEDULE IS SET AS FOLLOWS: Notices of Appearance due on or before 9/24/2020. Corporate Disclosure Statements due on or before 9/24/2020. Motion to Vacate with Brief in Support due on or before 9/24/2020. Consolidated Responses due on or before 10/15/2020. Reply, if any, due on or before 10/22/2020. #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines & Forms page of our website for additional information.Signed by Clerk of the Panel John W. Nichols on 9/10/2020. Associated Cases: MDL No. 2804, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850 (SM) |
Filing 3 NOTICE OF OPPOSITION TO CONDITIONAL TRANSFER ORDER (CTO-171) - 1 action(s) - re: pldg. ( #8419 in MDL No. 2804, 1 in OKW/5:20-cv-00850) Filed by Plaintiff Harmon County Board of County Commissioners (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, OKW/5:20-cv-00850 (Sill, Matthew) |
Filing 2 ***TEXT ONLY NOTICE***NOTICE OF FILING OF CTO AND PUBLICATION OF BRIEFING SCHEDULE (CTO-171) re: pldg. (1 in GAN/1:20-cv-03442, #8419 in MDL No. 2804, 2 in MOE/4:20-cv-01125, 2 in MOE/4:20-cv-01136, 1 in MOE/4:20-cv-01150, 1 in OKW/5:20-cv-00850, 1 in OKW/5:20-cv-00852) BRIEFING SCHEDULE IS SET AS FOLLOWS: Oppositions due on or before 9/9/2020. Signed by Clerk of the Panel John W. Nichols on 9/2/2020. Associated Cases: MDL No. 2804, GAN/1:20-cv-03442, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850, OKW/5:20-cv-00852 (SM) |
Filing 1 CONDITIONAL TRANSFER ORDER FILED TODAY (CTO-171) - 6 action(s) Signed by Clerk of the Panel John W. Nichols on 9/2/2020. Associated Cases: MDL No. 2804, GAN/1:20-cv-03442, MOE/4:20-cv-01125, MOE/4:20-cv-01136, MOE/4:20-cv-01150, OKW/5:20-cv-00850, OKW/5:20-cv-00852 (SM) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.